Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Heidemann
E. Heidemann
Deaconess Hospital
Randomized controlled trial
Oncology
Mitoxantrone
Epirubicin
Medicine
3
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
2002
Annals of Oncology
E. Heidemann
H. Stoeger
Rainer Souchon
Wolf-Dietrich Hirschmann
Heinrich Bodenstein
C. Oberhoff
J. T. Fischer
M. Schulze
M. Clemens
Reinhard Andreesen
M. Mahlke
M. König
Anton Scharl
K. Fehnle
Manfred Kaufmann
Show All
Source
Cite
Save
Citations (47)
Prognostic Subgroups: The Key Factor for Treatment Outcome in Metastatic Breast Cancer
1993
Onkologie
E. Heidemann
B. Steinke
J. H. Hartlapp
K. Schumacher
K. Possinger
S. Kunz
E. Neeser
G.v. Ingersleben
D. K. Hossfeld
H. Caffier
Rainer Souchon
R. Waldmann
E. Blumner
J Clark
Show All
Source
Cite
Save
Citations (13)
Randomized Clinical Trial Comparing Mitoxantrone with Epirubicin and with Doxorubicin, each Combined with Cyclophosphamide in the First-Line Treatment of Patients with Metastatic Breast Cancer
1990
Onkologie
E. Heidemann
B. Steinke
J. H. Hartlapp
K. Schumacher
K. Possinger
S. Kunz
E. Neeser
G.v. Ingersleben
D. K. Hossfeld
R. Waldmann
Show All
Source
Cite
Save
Citations (26)
1